RU97120507A - PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CHRONIC ALCOHOLISM - Google Patents

PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CHRONIC ALCOHOLISM

Info

Publication number
RU97120507A
RU97120507A RU97120507/14A RU97120507A RU97120507A RU 97120507 A RU97120507 A RU 97120507A RU 97120507/14 A RU97120507/14 A RU 97120507/14A RU 97120507 A RU97120507 A RU 97120507A RU 97120507 A RU97120507 A RU 97120507A
Authority
RU
Russia
Prior art keywords
treatment
chronic alcoholism
pharmaceutical compositions
alcoholism
chronic
Prior art date
Application number
RU97120507/14A
Other languages
Russian (ru)
Other versions
RU2153345C2 (en
Inventor
Морадзони Паоло
Бомбарделли Эцио
Original Assignee
Индена С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI950958A external-priority patent/IT1274481B/en
Application filed by Индена С.П.А. filed Critical Индена С.П.А.
Publication of RU97120507A publication Critical patent/RU97120507A/en
Application granted granted Critical
Publication of RU2153345C2 publication Critical patent/RU2153345C2/en

Links

Claims (3)

1. Применение липофильных экстрактов из корней Salvia miltiorrhyza Bunge, содержащих 5 - 30% в/в Tanshinone IIA и 0,5 - 3% в/в Miltirone для получения лекарственных препаратов для лечения хронического алкоголизма.1. The use of lipophilic extracts from the roots of Salvia miltiorrhyza Bunge containing 5-30% iv Tanshinone IIA and 0.5-3% iv Miltirone to obtain drugs for the treatment of chronic alcoholism. 2. Применение Tanshinone IIA для получения лекарственных препаратов для лечения хронического алкоголизма. 2. The use of Tanshinone IIA to obtain drugs for the treatment of chronic alcoholism. 3. Применение Miltirone для получения лекарственных препаратов для лечения хронического алкоголизма. 3. The use of Miltirone to obtain drugs for the treatment of chronic alcoholism.
RU97120507/14A 1995-05-12 1996-05-08 Agent for treatment of chronic alcoholics RU2153345C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI950958A IT1274481B (en) 1995-05-12 1995-05-12 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALCOHOL-DEPENDENCE
ITMI95A000958 1995-05-12

Publications (2)

Publication Number Publication Date
RU97120507A true RU97120507A (en) 1999-09-27
RU2153345C2 RU2153345C2 (en) 2000-07-27

Family

ID=11371582

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97120507/14A RU2153345C2 (en) 1995-05-12 1996-05-08 Agent for treatment of chronic alcoholics

Country Status (17)

Country Link
US (1) US5904923A (en)
EP (1) EP0824356B1 (en)
JP (1) JP2955370B2 (en)
KR (1) KR100290029B1 (en)
CN (1) CN1066336C (en)
AT (1) ATE221384T1 (en)
AU (1) AU695010B2 (en)
CA (1) CA2220703C (en)
DE (1) DE69622704T2 (en)
DK (1) DK0824356T3 (en)
ES (1) ES2180783T3 (en)
HK (1) HK1009096A1 (en)
IT (1) IT1274481B (en)
NO (1) NO318659B1 (en)
PT (1) PT824356E (en)
RU (1) RU2153345C2 (en)
WO (1) WO1996035441A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3570989B2 (en) 1997-07-30 2004-09-29 インデナ エッセ ピ ア Soy extract, preparation method thereof and pharmaceutical composition
US5968746A (en) 1997-11-26 1999-10-19 Schneider; David R. Method and apparatus for preserving human saliva for testing
AU2001286409A1 (en) * 2000-08-03 2002-02-18 Hong Kong University Of Science And Technology N-methyl-d-aspartate receptor antagonists
CN1304723A (en) * 2001-01-16 2001-07-25 中山大学 Tanshinone compounds containing dihydrofuran ring structure used for medicine to treat hepatic encephalopathy
US6852342B2 (en) 2002-03-26 2005-02-08 Avoca, Inc. Compounds for altering food intake in humans
WO2004058245A1 (en) * 2002-12-31 2004-07-15 Zhongshan Univertsity Tanshinone iia for prophylaxising or treating atherosclerosis
US9827314B2 (en) * 2003-12-08 2017-11-28 Mars, Incorporated Edible compositions which are adapted for use by a companion animal
JP2008538748A (en) * 2005-04-07 2008-11-06 ハイシアム， インコーポレイテッド Improved methods and compositions for the prevention of anxiety, substance abuse and dependence
GB201312205D0 (en) * 2013-07-08 2013-08-21 Univ Leuven Kath Anticonvulsant activity of dan shen extracting compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1239281B (en) * 1989-10-27 1993-10-19 Indena Spa COMPOSITIONS FOR THE REDUCTION OF SUPERFLUOUS FATTY DEPOSITS BASED ON ACTIVE PRINCIPLES OF VEGETABLE ORIGIN TO AGONISTIC ACTIVITY OF THE ADENYLATE CYCLASE OR / AND TO ANTI-PHOSPHODIESTERASIC ACTIVITY
US5204369A (en) * 1991-07-01 1993-04-20 The Endowment For Research In Human Biology Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse

Similar Documents

Publication Publication Date Title
ATE207468T1 (en) AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
IL116674A (en) Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
NO971206D0 (en) Prolonged-frigjöringsformulering
MA24193A1 (en) PROCESSES FOR THE PREPARATION OF A PHYSIOLOGICALLY ACTIVE PEG-IFN ALPHA CONJUGATE, AND FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND THEIR USE
DZ2009A1 (en) New taxoids, their preparation and the pharmaceutical compositions containing them.
ATE250593T1 (en) TAXAL DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
YU49423B (en) Tetrahydrolipstatin containing compositions
EE9600118A (en) New oral pharmaceutical dosage form
CA2339991A1 (en) Microemulsions as solid dosage forms for oral administration
DE69618587D1 (en) CHINAZOLINE AND PHARMACEUTICAL COMPOSITIONS
EA200300081A1 (en) HYDROGEL-CONTROLLED MEDICINE FORM
DE69618210D1 (en) AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
RU97120507A (en) PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CHRONIC ALCOHOLISM
FR2697841B1 (en) New taxane derivatives, their preparation and the pharmaceutical compositions containing them.
ATE193533T1 (en) TAXAL DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE69706146D1 (en) TAXOIDS, THEIR PRODUCTION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE195940T1 (en) TAXOL DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA2220703A1 (en) Pharmaceutical compositions for the treatment of alcohol addiction
ATE151774T1 (en) CYCLOPENTANPERHYDROPHENANTHRENE-17-BETA-(3-FURYL - 3-DERIVATIVES AND PHARMACEUTICAL PREPARATIONS THEREOF FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
DE69223835D1 (en) New aminophenol derivatives and pharmaceutical compositions containing them
ATE205204T1 (en) BENZOPYRANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
DE69715247D1 (en) QUINUPRISTIN AND DALFOPRISTIN-BASED STABILIZED PHARMACEUTICAL COMPOSITION, AND THE PREPARATION THEREOF
ATE204265T1 (en) NEW TAXOIDS, PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2749586B1 (en) NOVEL DEVICES FOR THE TRANSDERMAL ADMINISTRATION OF TRIMEGESTONE, THEIR PREPARATION METHOD AND THEIR APPLICATION AS MEDICAMENTS
ATE289515T1 (en) CELERY SEED EXTRACTS FOR THE PREVENTION AND TREATMENT OF INFLAMMATION AND GASTROINTESTINAL IRRITATIONS